Pharmaron Beijing Co Ltd - Asset Resilience Ratio

Latest as of September 2025: 4.17%

Pharmaron Beijing Co Ltd (300759) has an Asset Resilience Ratio of 4.17% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Pharmaron Beijing Co Ltd (300759) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Liquid Assets

CN¥1.08 Billion

≈ $157.33 Million USD Cash + Short-term Investments

Total Assets

CN¥25.80 Billion

≈ $3.78 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2018–2024)

This chart shows how Pharmaron Beijing Co Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see 300759 total assets.

Liquid Assets Composition Over Time

This chart breaks down Pharmaron Beijing Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Read 300759 current and long-term liabilities for a breakdown of total debt and financial obligations.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.08 Billion	4.17%
Total Liquid Assets	CN¥1.08 Billion	4.17%

Asset Resilience Insights

Limited Liquidity: Pharmaron Beijing Co Ltd maintains only 4.17% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Pharmaron Beijing Co Ltd Industry Peers by Asset Resilience Ratio

Compare Pharmaron Beijing Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Ligand Pharmaceuticals Incorporated NASDAQ:LGND	Biotechnology	16.06%
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Revolution Medicines Inc NASDAQ:RVMD	Biotechnology	72.23%
Abivax SA PA:ABVX	Biotechnology	2.34%
Shanghai Allist Pharmaceuticals Co. Ltd. A SHG:688578	Biotechnology	21.11%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
SOLENO THERAPEUT. DL-001 F:6XC	Biotechnology	41.74%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Annual Asset Resilience Ratio for Pharmaron Beijing Co Ltd (2018–2024)

The table below shows the annual Asset Resilience Ratio data for Pharmaron Beijing Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	4.66%	CN¥1.12 Billion ≈ $163.20 Million	CN¥23.93 Billion ≈ $3.50 Billion	+2.42pp
2023-12-31	2.24%	CN¥594.33 Million ≈ $86.97 Million	CN¥26.48 Billion ≈ $3.87 Billion	-1.39pp
2022-12-31	3.64%	CN¥745.36 Million ≈ $109.07 Million	CN¥20.49 Billion ≈ $3.00 Billion	-4.82pp
2021-12-31	8.45%	CN¥1.55 Billion ≈ $227.49 Million	CN¥18.39 Billion ≈ $2.69 Billion	+0.81pp
2020-12-31	7.64%	CN¥910.01 Million ≈ $133.16 Million	CN¥11.91 Billion ≈ $1.74 Billion	+5.79pp
2019-12-31	1.85%	CN¥183.45 Million ≈ $26.84 Million	CN¥9.94 Billion ≈ $1.45 Billion	+1.84pp
2018-12-31	0.01%	CN¥412.62K ≈ $60.38K	CN¥4.63 Billion ≈ $676.85 Million	--

pp = percentage points

About Pharmaron Beijing Co Ltd

SHE:300759 China Biotechnology

Market Cap

$8.92 Billion

CN¥60.93 Billion CNY

Market Cap Rank

#2456 Global

#272 in China

Share Price

CN¥41.26

Change (1 day)

+0.17%

52-Week Range

CN¥21.72 - CN¥51.15

All Time High

CN¥10080.27